RxDoctor Payments Data

Paola Yanez

Family · Rancho Cucamonga, CANPI 1790360659

Payments from drug & device makers

$2,561in general payments, 2019–2025

Across 119 payments — averaging $21.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$360
  • Novo Nordisk$308
  • Exact Sciences$281
  • Bayer$238
  • Pfizer$151
  • AstraZeneca$150
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$2,554100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,561 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide75$88,001
JardianceEmpagliflozin33$47,415
EliquisApixaban26$33,144
JanuviaSitagliptin Phosphate15$17,983
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$2,257
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$2,244
Atorvastatin Calcium234$1,870
Pregabalin16$1,709
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen68$1,643
Potassium Chloride34$1,282
Levothyroxine Sodium75$1,086
Albuterol Sulfate HfaAlbuterol Sulfate27$950
Gabapentin46$881
Losartan Potassium99$859
Trazodone Hcl49$767

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$308$88,00175 claims
Boehringer IngelheimJardiance$26$47,41533 claims
PfizerEliquis$151$33,14426 claims
MerckJanuvia$111$17,98315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,634 family providers in California.

Other family in Rancho Cucamonga

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →